Apellis PharmaceuticalsAPLS
那斯達克 · USD
24.97
+0.29
(+1.15%)
收盤 12/12 04:59 (UTC+8)
盤後
25.03
+0.07
(+0.26%)
12/12 04:59 (UTC+8)
Apellis PharmaceuticalsAPLS
24.97
+0.29
(+1.15%)
財務數據
損益表
- 0.95
- 1.10
- 1.46
- 1.72
- 2.00
- 1.97
- 2.13
- 1.67
- 1.78
- 4.59
- 111.76
- 16.25
- 32.59
- 17.73
- 15.88
- -1.43
- 7.98
- -21.52
- 7.01
- 156.92
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 458,578 | 178,494 | 166,797 | 212,528 | 196,830 | 199,684 | 172,325 | 146,377 | 110,400 | 94,968 |
營業成本 | 24,531 | 13,626 | 34,360 | 40,856 | 33,558 | 23,100 | 20,209 | 19,912 | 22,410 | 8,379 |
營業毛利 | 434,047 | 164,868 | 132,437 | 171,672 | 163,272 | 176,584 | 152,116 | 126,465 | 87,990 | 86,589 |
營業費用 | 210,864 | 198,154 | 215,765 | - | 210,553 | - | - | - | 225,069 | 207,030 |
研發費用 | 68,186 | 67,015 | 86,420 | 76,354 | 88,569 | 77,946 | 84,701 | 69,282 | 79,421 | 95,657 |
推銷及管理費用 | 142,678 | 131,139 | 129,345 | 121,482 | 121,984 | 128,082 | 129,505 | 141,701 | 145,648 | 111,373 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 223,183 | -33,286 | -83,328 | -26,164 | -47,281 | -29,444 | -62,090 | -84,518 | -137,079 | -120,441 |
其他收入及費用 | 4,413 | 2,753 | 2,493 | 1,631 | 2,959 | 1,260 | 2,804 | 4,767 | 4,385 | 5,938 |
利息費用 | 11,279 | 11,152 | 11,049 | 11,534 | 12,531 | 9,359 | 6,967 | 7,402 | 7,310 | 7,340 |
稅前純益 | 216,317 | -41,685 | -91,884 | -36,067 | -56,853 | -37,543 | -66,253 | -87,153 | -140,004 | -121,843 |
所得稅 | 602 | 466 | 341 | 286 | 592 | 114 | 170 | 1,423 | 233 | 194 |
稅後純益 | 215,715 | -42,151 | -92,225 | -36,353 | -57,445 | -37,657 | -66,423 | -88,576 | -140,237 | -122,037 |
基本每股稅後盈餘(元) | 1.71 | -0.33 | -0.74 | -0.30 | -0.46 | -0.30 | -0.54 | -0.73 | -1.17 | -1.02 |
稀釋每股稅後盈餘(元) | 1.72 | -0.33 | -0.74 | -0.29 | -0.47 | -0.30 | -0.54 | -0.72 | -1.16 | -1.01 |
基本平均股數(千股) | 126424.00 | 126024.00 | 125453.00 | 124525.00 | 124234.00 | 123904.00 | 122957.00 | 121232.00 | 120292.00 | 119316.00 |
稀釋平均股數(千股) | 130067.00 | 126024.00 | 125453.00 | 124525.00 | 124234.00 | 123904.00 | 122957.00 | 121232.00 | 120292.00 | 119316.00 |
還原基本每股稅後盈餘(元) | 1.71 | -0.33 | -0.74 | -0.30 | -0.46 | -0.30 | -0.54 | -0.73 | -1.17 | -1.02 |
還原稀釋每股稅後盈餘(元) | 1.72 | -0.33 | -0.74 | -0.29 | -0.47 | -0.30 | -0.54 | -0.72 | -1.16 | -1.01 |
還原基本平均股數(千股) | 126,424 | 126,024 | 125,453 | 124,525 | 124,234 | 123,904 | 122,957 | 121,232 | 120,292 | 119,316 |
還原稀釋平均股數(千股) | 130,067 | 126,024 | 125,453 | 124,525 | 124,234 | 123,904 | 122,957 | 121,232 | 120,292 | 119,316 |
EBITDA(千元) | 228,571 | -29,473 | -79,798 | -23,499 | -43,207 | -24,627 | -52,700 | -72,775 | -125,838 | -107,596 |